Balaveda has raised nearly $1.2 million as it looks to chip away at 5-Hour Energy’s dominance by winning over consumers seeking better-for-you alternatives.
Collected from 14 friends-and-family investors, the funding will help the beverage brand support its growing retail network, which could hit as many as 3,000 doors by the end of the year, up from 670 today. Balaveda’s sales are up 400% year over year, according to co-founder Sebastian Smith, and the brand is on pace to become profitable in the first quarter next year and generate $3 million to $4 million in 2027 sales.
“This is a new world where people care about their health and what they’re putting into their body. The money is not important to us,” says Smith. “We understand we need money to grow and have a business, and our investors want to be happy with us making money, but the most important thing is we want to put health back in people’s hands and give people a choice to choose something that’s healthier.”
Balaveda’s assortment contains 10 stockkeeping units, including seven functional shots spanning energy, immunity and beauty-focused collagen offerings, and three nootropic powders. Its energy shots contain 90 to 180 milligrams of plant-based caffeine from organic green coffee and matcha, paired with ingredients including L-theanine, cordyceps and eleuthero.
Housed in glass, the shots are organic and avoid synthetic dyes and artificial flavors. Benchmarked against 5-Hour Energy, whose regular-strength shot contains 200 milligrams of caffeine, Smith says Balaveda’s shots are priced at $3.99 apiece, with prices varying by retailer. Individual 5-Hour Energy shots typically sell for $3 to $3.50 at major retailers. Supersonic Citrus and Totally Turmeric are among Balaveda’s bestselling shots.
Balaveda’s origin story is in part a story of a marriage. Smith, whose background is in photography and filmmaking, was traveling about 200 days a year for work while his wife and Balaveda co-founder, Amanda Hester-Smith, was home on the couple’s Tennessee farm and became incredibly anxious every time he was about to take off. She visited a doctor to see if there was a remedy for her anxiety, and the doctor recommended a prescription. Hester-Smith, who studied Ayurveda, herbal medicine and nutrition, instead drew on her training to formulate a solution herself.
Rooted in her formulation, Balaveda started with adaptogenic smoothies in early 2020 and quickly landed in about 30 stores. Weeks later, the COVID-19 pandemic brought that momentum to a halt. As stores shut down, the brand lost those accounts and its ability to educate shoppers in person about adaptogens and the functional benefits of its ingredients. Balaveda pivoted to immunity shots that resonated with consumers focused on their health.
Today, consumers are far more familiar with functional beverages, and demand for products promising advantages beyond hydration is rising. The functional shots market in the U.S. generated an estimated $243 million in 2024 and is projected to expand at a compound annual growth rate of 15.2% through 2033, according to Grand View Research. Energy products accounted for 41.6% of the market.
“We want to put health back in people’s hands and give people a choice to choose something that’s healthier.”
The U.S. wellness shots category grew more than 28% over the 52 weeks ended March 23, 2026, according to SPINS data cited in Suja Life’s IPO prospectus. Smith believes consumers are gravitating to shots because they’re interested in functional products in a convenient, grab-and-go format. He says Balaveda’s core consumers are split evenly between men and women and are generally 19 to 40. He figures half are turning to Balaveda to address afternoon slumps.
Launched by entrepreneur Manoj Bhargava in 2004, 5-Hour Energy has long led the energy shots category, accounting for roughly 85% of category sales in 2024, according to Circana. However, Mintel finds that its grip is slipping as health consciousness spreads. That’s creating room for competitors such as Balaveda, Suja, Suja-owned Vive Organic, Ethan’s and Sol-ti to gain share.
Retailers see potential in the new crop of energy shot upstarts, too. Balaveda has entered retailers including Twice Daily, Lassen’s, Mollie Stone’s Market and Berkeley Bowl, along with select 7-Eleven locations and other convenience stores. Smith says the brand is preparing to launch at Kroger. He discloses its sales are up 700% on Amazon this year.
Balaveda’s retail expansion has been aided by KeHE, which selected it as a Golden Ticket winner through its Trend Finder program, bringing it into the distributor’s brand roster. KeHE reaches more than 31,000 retail locations. Smith says Balaveda is currently distributed through three KeHE distribution centers, with two more slated to open to the brand in the spring. Balaveda also has partnerships with five direct-store delivery (DSD) distributors to increase its store footprint.
The brand has more products in the pipeline as it expands distribution. Hester-Smith formulates its products and has developed 26 potential beverage recipes ranging from bone health and protein to menstrual cycle support. Smith says Balaveda is working on a new product for spring 2027 and is discussing an exclusive nootropic powder with a major natural foods retailer for the same period.
On the marketing front, Balaveda is pursuing community partnerships and experiential activations to connect with health-conscious consumers. Smith says the goal is to build relationships with like-minded communities rather than rely solely on social media to drive awareness. Another audience Smith hopes to cultivate is athletes, with the brand already attracting boxers and mixed martial arts fighters and the NFL on his wish list.
Although Balaveda has turned down opportunities to avoid growing too quickly, Smith expects the brand to eventually pursue institutional funding to propel broader expansion. “If you look at a brand like Suja, it had Coke and Goldman Sachs invest in them because they were ready to make that big national play,” he says. “I do believe we will get to that point.”
Click here to secure tickets to Dealmaker Summit running from Nov. 9 to 10 in London.